Chemo-radiation (CRT) and mutation profile in stage III Non Small Cell Lung Cancer (NSCLC): An analysis of the prognostic value

被引：0
|
作者：
Boros, A. [1 ]
Lacroix, L. [2 ]
Lacas, B. [3 ]
Adam, J. [2 ]
Pignon, J. P. [3 ]
Caramella, C. [4 ]
Planchard, D. [5 ]
Levy, A. [1 ]
Montpreville, V. [6 ]
Deutsch, E. [1 ]
Besse, B. [5 ]
Le Pechoux, C. [1 ]
机构：
[1] Gustave Roussy, Radiat Oncol, Villejuif, France
[2] Gustave Roussy, Biopathol, Villejuif, France
[3] Gustave Roussy, Biostat, Villejuif, France
[4] Gustave Roussy, Radiol, Villejuif, France
[5] Gustave Roussy, Med Oncol, Villejuif, France
[6] Marie Lannelongue Ctr, Pathol, Le Plessis Robinson, France
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(15)30056-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3000
引用
收藏
页码：S595 / S595
页数：1
相关论文
共 50 条
  • [41] Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC).
    Abacioglu, U
    Yumuk, PF
    Caglar, H
    Sengoz, M
    Turhal, NS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 695S - 695S
  • [42] PROGNOSTIC FACTORS IN UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER
    Boku, S.
    Kasamatsu, Y.
    Kida, T.
    Kasamatsu, Y.
    [J]. ANNALS OF ONCOLOGY, 2013, 24
  • [43] Survival benefit from combined chemoradiation (CRT) in elderly patients with unresectable stage III non-small cell lung cancer (NSCLC).
    Domingues, Pedro Masson
    Zylberberg, Ricardo
    Matta-Castro, Thalita
    Baldotto, Clarissa Serodio
    de Lima Araujo, Luiz Henrique
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Cisplatin and etoposide followed by concurrent chemo-radiation therapy for limited stage small cell lung cancer (SCLC-LS).
    Benedetti, G
    Fedele, M
    Tamberi, S
    Rastelli, F
    Finocchiaro, G
    Maestri, A
    Salvi, F
    Calandri, C
    Frezza, G
    Crino, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 704S - 704S
  • [45] Radiation therapy of stage I and II non-small cell lung cancer (NSCLC)
    Zierhut, D
    Bettscheider, C
    Schubert, K
    van Kampen, M
    Wannenmacher, M
    [J]. LUNG CANCER, 2001, 34 : S39 - S43
  • [46] Prognostic Value and Reproducibility of Pretreatment CT Texture Features in Stage III Non-Small Cell Lung Cancer
    Fried, D.
    Tucker, S.
    Zhou, S.
    Liao, Z.
    Mawlawi, O.
    Ibbott, G.
    Court, L.
    [J]. MEDICAL PHYSICS, 2014, 41 (06) : 408 - 409
  • [47] Prognostic Value and Reproducibility of Pretreatment CT Texture Features in Stage III Non-Small Cell Lung Cancer
    Fried, David V.
    Tucker, Susan L.
    Zhou, Shouhao
    Liao, Zhongxing
    Mawlawi, Osama
    Ibbott, Geoffrey
    Court, Laurence E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (04): : 834 - 842
  • [48] Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer
    van Baardwijk, Angela
    Reymen, Bart
    Wanders, Stofferinus
    Borger, Jacques
    Ollers, Michel
    Dingemans, Anne-Marie C.
    Bootsma, Gerben
    Geraedts, Wiel
    Pitz, Cordula
    Lunde, Ragnar
    Peters, Frank
    Lambin, Philippe
    De Ruysscher, Dirk
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 (15) : 2339 - 2346
  • [49] Vinorelbine (VNR) plus concurrent thoracic radiation therapy (TR) in non small cell lung cancer (NSCLC) stage III
    Portalone, L
    Brocchieri, P
    Seta, R
    Greco, S
    Lombardi, A
    Luca, F
    Nunziati, F
    Signora, M
    [J]. LUNG CANCER, 2005, 49 : S381 - S382
  • [50] Outcomes of Hypofractionated Radiation Therapy (HFRT) with Concurrent Chemotherapy in Patients with Stage III Non Small Cell Lung Cancer (NSCLC)
    Shepherd, A.
    Gelblum, D.
    Wu, A.
    Rimner, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S661 - S662
12345